Market Tracker

03/29 9:06am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.24
Delayed Data
As of Mar 28
 +0.11 / +2.66%
Today’s Change
1.65
Today|||52-Week Range
6.49
+143.68%
Year-to-Date

Today’s Trading

Previous close4.13
Today’s open4.28
Day’s range4.05 - 4.35
Volume183,004
Average volume (3 months)594,421
Market cap$61.8M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-19.13%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
ZSANZosano Pharma Corp+0.18+10.59%
NBYNovaBay Pharmaceutic...+0.15+4.00%
CEMIChembio Diagnostics ...-0.10-1.85%
MEIPMEI Pharma Inc0.000.00%
Data as of 03/28/2017

Financials

Last reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts